134 related articles for article (PubMed ID: 6314716)
21. [Observations on the reactions following vaccination of the inactivated Japanese encephalitis virus vaccine from tissue culture (author's transl)].
Zhonghua Yu Fang Yi Xue Za Zhi; 1981 Mar; 15(2):98-100. PubMed ID: 7307821
[No Abstract] [Full Text] [Related]
22. Recombinant, chimaeric live, attenuated vaccine (ChimeriVax) incorporating the envelope genes of Japanese encephalitis (SA14-14-2) virus and the capsid and nonstructural genes of yellow fever (17D) virus is safe, immunogenic and protective in non-human primates.
Monath TP; Soike K; Levenbook I; Zhang ZX; Arroyo J; Delagrave S; Myers G; Barrett AD; Shope RE; Ratterree M; Chambers TJ; Guirakhoo F
Vaccine; 1999 Apr; 17(15-16):1869-82. PubMed ID: 10217584
[TBL] [Abstract][Full Text] [Related]
23. Japanese encephalitis vaccine.
Oya A
Acta Paediatr Jpn; 1988 Apr; 30(2):175-84. PubMed ID: 2854351
[No Abstract] [Full Text] [Related]
24. [Reactogenicity and immunological effectiveness of a concentrated, purified vaccine against tick-borne encephalitis].
Vorob'eva MS; El'bert LB; Grachev VP; Lelikov VL; Pervikov IuV
Vopr Virusol; 1983; 28(5):622-6. PubMed ID: 6659477
[TBL] [Abstract][Full Text] [Related]
25. Immunogenicity of live attenuated SA14-14-2 Japanese encephalitis vaccine--a comparison of 1- and 3-month immunization schedules.
Tsai TF; Yu YX; Jia LL; Putvatana R; Zhang R; Wang S; Halstead SB
J Infect Dis; 1998 Jan; 177(1):221-3. PubMed ID: 9419193
[TBL] [Abstract][Full Text] [Related]
26. Safety and immunogenicity of a delta inulin-adjuvanted inactivated Japanese encephalitis virus vaccine in pregnant mares and foals.
Bielefeldt-Ohmann H; Prow NA; Wang W; Tan CS; Coyle M; Douma A; Hobson-Peters J; Kidd L; Hall RA; Petrovsky N
Vet Res; 2014 Dec; 45(1):130. PubMed ID: 25516480
[TBL] [Abstract][Full Text] [Related]
27. Long-term follow-up of Japanese encephalitis chimeric virus vaccine: Immune responses in children.
Chokephaibulkit K; Sirivichayakul C; Thisyakorn U; Pancharoen C; Boaz M; Bouckenooghe A; Feroldi E
Vaccine; 2016 Nov; 34(46):5664-5669. PubMed ID: 27686833
[TBL] [Abstract][Full Text] [Related]
28. Immunogenicity and protective efficacy of the current inactivated Japanese encephalitis vaccine against different Japanese encephalitis virus strains.
Kurane I; Takasaki T
Vaccine; 2000 May; 18 Suppl 2():33-5. PubMed ID: 10821971
[TBL] [Abstract][Full Text] [Related]
29. [Immunity indices of mice immunized with different vaccines against Japanese encephalitis].
Pervikov IuV; El'bert LB; Karaseva PS; Lisitsina EA
Vopr Virusol; 1984; 29(3):337-42. PubMed ID: 6087567
[TBL] [Abstract][Full Text] [Related]
30. Japanese encephalitis DNA vaccine candidates expressing premembrane and envelope genes induce virus-specific memory B cells and long-lasting antibodies in swine.
Konishi E; Yamaoka M; Kurane I; Mason PW
Virology; 2000 Mar; 268(1):49-55. PubMed ID: 10683326
[TBL] [Abstract][Full Text] [Related]
31. Japanese encephalitis vaccine and adverse effects among travellers.
Robinson HC; Russell ML; Csokonay WM
Can Dis Wkly Rep; 1991 Aug; 17(32):173-4, 177. PubMed ID: 1657420
[No Abstract] [Full Text] [Related]
32. Immunogenicity, genetic stability, and protective efficacy of a recombinant, chimeric yellow fever-Japanese encephalitis virus (ChimeriVax-JE) as a live, attenuated vaccine candidate against Japanese encephalitis.
Guirakhoo F; Zhang ZX; Chambers TJ; Delagrave S; Arroyo J; Barrett AD; Monath TP
Virology; 1999 May; 257(2):363-72. PubMed ID: 10329547
[TBL] [Abstract][Full Text] [Related]
33. The efficacy of Japanese encephalitis vaccine in Henan, China: a case-control study.
Luo D; Yin H; Xili L; Song J; Wang Z
Southeast Asian J Trop Med Public Health; 1994 Dec; 25(4):643-6. PubMed ID: 7667706
[TBL] [Abstract][Full Text] [Related]
34. Superior immunogenicity of a freeze-dried, cell culture-derived Japanese encephalitis vaccine (inactivated).
Kikukawa A; Gomi Y; Akechi M; Onishi T; Manabe S; Namazue J; Fuke I; Ishikawa T; Okuno Y; Ueda S
Vaccine; 2012 Mar; 30(13):2329-35. PubMed ID: 22306856
[TBL] [Abstract][Full Text] [Related]
35. Japanese encephalitis immunization in South Korea: past, present, and future.
Sohn YM
Emerg Infect Dis; 2000; 6(1):17-24. PubMed ID: 10653564
[TBL] [Abstract][Full Text] [Related]
36. New Japanese encephalitis vaccines: alternatives to production in mouse brain.
Halstead SB; Thomas SJ
Expert Rev Vaccines; 2011 Mar; 10(3):355-64. PubMed ID: 21434803
[TBL] [Abstract][Full Text] [Related]
37. Japanese encephalitis vaccines: current vaccines and future prospects.
Monath TP
Curr Top Microbiol Immunol; 2002; 267():105-38. PubMed ID: 12082985
[TBL] [Abstract][Full Text] [Related]
38. Japanese encephalitis vaccines: Immunogenicity, protective efficacy, effectiveness, and impact on the burden of disease.
Hegde NR; Gore MM
Hum Vaccin Immunother; 2017 Jun; 13(6):1-18. PubMed ID: 28301270
[TBL] [Abstract][Full Text] [Related]
39. Immunogenicity of low dose Japanese encephalitis vaccine (BIKEN) administered by the intradermal route: preliminary data.
Intralawan P; Paupunwatana S
Asian Pac J Allergy Immunol; 1993 Jun; 11(1):79-83. PubMed ID: 8216563
[TBL] [Abstract][Full Text] [Related]
40. Japanese Encephalitis Vaccines: WHO position paper – February 2015.
Wkly Epidemiol Rec; 2015 Feb; 90(9):69-87. PubMed ID: 25726573
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
